Contraline

Drug Discovery · Charlottesville, VA · Founded 2015 · Privately Held (backing)

Developer of a male contraceptive product intended to provide non-surgical and reversible birth control procedures. Contraline is based in Charlottesville, VA and was founded in 2015. Its last reported valuation was $60 million in Feb 2025. It has raised $41.7 million across 3 recorded rounds; the latest was a $55.8 million later-stage round in May 2026.

Last reported valuation
$60.0M
Oct 2026
Priced at
—
Total raised
$41.7M
Last round
Later Stage VC
May 2026

Who backs Contraline?

52 investors
InvestorType
Alumni VenturesVenture capital
Kima VenturesVenture capital
GaingelsVenture capital
Metaplanet HoldingsVenture capital
GVVenture capital
Founders FundVenture capital
Abstract VenturesVenture capital
Evolution VC PartnersVenture capital
LAUNCH FundOther
Flight VenturesVenture capital
+ 42 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Contraline investors

52 investors are on record for Contraline, including Alumni Ventures, Kima Ventures, Gaingels and Metaplanet Holdings. By type, the record holds 14 venture capital firms and 1 angel investor. The later-stage round in May 2026 drew 77 investors.

Free account
More of Contraline with a free account
  • ·The complete investor list: 52 names
  • ·Watch Contraline: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 52 firms already write checks for companies like Contraline in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View